Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.3.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
unclassifiableEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCEEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.507EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.196EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.459EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.117EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.381EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.382EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.395EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.153EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.391EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.448EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.1 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.99 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.322EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.416EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used